Faculty

Institution

Unit

Venue

Sierra Colavito

University of Wisconsin--La Crosse

Affiliations

Academic Affairs

College of Science & Health

Department of Biology

University of Wisconsin--La Crosse

NoneSierra Colavito is currently serving as a Academic Affairs faculty at University of Wisconsin--La Crosse.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sierra Colavito

University of Wisconsin--La Crosse

You can click a keyword to filter the displayed items

oncology radiation oncology cancer research breast cancer medicinal research oncogenes cancer biology systems biology radiology genetics therapeutic targets tumor biology cell signaling neuro-oncology gliomas cellular therapy cancer discovery cancer cells brain tumor research tumor suppressors cancer treatment x-ray free-electron laser drug targets cancer genomics pathway analysis signaling pathways cancer genetics breast oncology breast cancer therapy claudin-low breast cancer nuclear factor kappa-light-chain-enhancer triple-negative breast cancer induced mesenchymal transformation combinatorial drug screening drug combinations mammary cells

Notable Scholarly Works

Notable Federal Grants

Collaborators

Axl as a Target in Breast Cancer Therapy. Journal of Oncology (2020)

Sierra A. Colavito

cancer discoverytherapeutic targetsbreast cancertumor biologybreast cancer therapyradiologycancer researchtumor suppressorscancer cellscancer treatmentoncogenesradiation oncologyx-ray free-electron lasermedicinal researchcellular therapysystems biologycancer biologydrug targetsoncology

Combinatorial Drug Screening of Mammary Cells With Induced Mesenchymal Transformation to Identify Drug Combinations for Triple-Negative Breast Cancer. Oncotarget (2019)

Sierra A. ColavitoJames T. PlattMatthew A. HeldZongzhi LiuRyan SokupDavid F. Stern

breast oncologyradiation oncologymammary cellsinduced mesenchymal transformationcombinatorial drug screeningpharmacologytriple-negative breast cancerdrug combinationsoncologybreast cancer

Significance of Glioma-Associated Oncogene Homolog 1 (Gli1)Expression in Claudin-Low Breast Cancer and Crosstalk With the Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NfκB) Pathway. Breast Cancer Research (2014)

Sierra A ColavitoMike R ZouQin YanDon X NguyenDavid F Stern

neurologyoncogenesneuro-oncologycancer biologyclaudin-low breast cancergliomascell signalingmedicinal researchbrain tumor researchsignaling pathwayscancer researchpathway analysispharmacologycancer geneticscancer genomicsoncologygeneticsnuclear factor kappa-light-chain-enhancer

1
10 / page

Sierra Colavito

University of Wisconsin--La Crosse

Affiliations

Academic Affairs

College of Science & Health

Department of Biology

University of Wisconsin--La Crosse

NoneSierra Colavito is currently serving as a Academic Affairs faculty at University of Wisconsin--La Crosse.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sierra Colavito

University of Wisconsin--La Crosse

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Axl as a Target in Breast Cancer Therapy. Journal of Oncology (2020)

Sierra A. Colavito

Combinatorial Drug Screening of Mammary Cells With Induced Mesenchymal Transformation to Identify Drug Combinations for Triple-Negative Breast Cancer. Oncotarget (2019)

Sierra A. ColavitoJames T. PlattMatthew A. HeldZongzhi LiuRyan SokupDavid F. Stern

breast oncologyradiation oncologymammary cellsinduced mesenchymal transformationcombinatorial drug screeningpharmacologytriple-negative breast cancerdrug combinationsoncologybreast cancer

Sierra A ColavitoMike R ZouQin YanDon X NguyenDavid F Stern

1
10 / page